|Day Low/High||196.30 / 198.36|
|52 Wk Low/High||144.75 / 199.85|
If you currently hold Stryker shares, consider selling and swapping into much better values.
It becomes difficult for me to tell you where to run in these markets...
Here are some options strategies for this FANG name into tomorrow's report.
The crash of oil will only accelerate the move.
KLA-Tencor, Microsoft and Intel all report earnings after the close Thursday.
Sectors are saying different things about rates, but new Fed chief Jerome Powell could provide clarity at his first press conference on Wednesday.
You might actually be grateful that stocks took one on the jaw on Monday.
The forces that artificially impacted the marketplace return to normal; so will the marketplace itself.
Demand for artificial joints is growing, and Zimmer Biomet is a good way to play the demographic trend.
It's a wonder to me how split this market really is.
We know that we are in the era when index managers are ascendant.
There are nearly too many surging sectors to count.
A one-day pullback wouldn't turn me into a bear.
Investors shouldn't be buying certain healthcare stocks based on Donald Trump's nomination of Tom Price as HHS chief, says Jim Cramer.
A rising daily OBV line makes me bullish on the next move for SYK.
But several airline and retail stocks are proving highly volatile.
Chipotle, Wendy's on the bull side and gold stocks on the bear side.
The volatility created by the Brexit vote makes several stocks particularly attractive buys.
This market has taken some frantic turns from one group to the other.
As Johnson & Johnson surveys the M&A scene, investors would be wise to keep Stryker on their radars, Real Money's Jim Cramer says.
Apple’s quarterly earnings report failed to inspire Wall Street traders last week, but investors should remain energetic about the tech giant’s stock.